AU5591694A - Composition protective against (p. multocida) pasteurellosis infection - Google Patents

Composition protective against (p. multocida) pasteurellosis infection

Info

Publication number
AU5591694A
AU5591694A AU55916/94A AU5591694A AU5591694A AU 5591694 A AU5591694 A AU 5591694A AU 55916/94 A AU55916/94 A AU 55916/94A AU 5591694 A AU5591694 A AU 5591694A AU 5591694 A AU5591694 A AU 5591694A
Authority
AU
Australia
Prior art keywords
pasteurellosis
multocida
infection
protective against
composition protective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55916/94A
Other languages
English (en)
Inventor
Keum Hwa Choi
Samuel K Maheswaran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota filed Critical University of Minnesota
Publication of AU5591694A publication Critical patent/AU5591694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU55916/94A 1992-11-06 1993-11-05 Composition protective against (p. multocida) pasteurellosis infection Abandoned AU5591694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97307092A 1992-11-06 1992-11-06
US973070 1992-11-06
PCT/US1993/010600 WO1994011024A1 (en) 1992-11-06 1993-11-05 Composition protective against p. multocida pasteurellosis infection

Publications (1)

Publication Number Publication Date
AU5591694A true AU5591694A (en) 1994-06-08

Family

ID=25520459

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55916/94A Abandoned AU5591694A (en) 1992-11-06 1993-11-05 Composition protective against (p. multocida) pasteurellosis infection

Country Status (5)

Country Link
EP (1) EP0668779A4 (de)
JP (1) JPH08503136A (de)
AU (1) AU5591694A (de)
CA (1) CA2148829A1 (de)
WO (1) WO1994011024A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76975A (hu) 1994-12-09 1998-01-28 Imperial College Innovations Limited Eljárás gének azonosítására
CA2341349C (en) 1998-09-04 2013-12-10 Creatogen Aktiengesellschaft Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof
AU2010201539C1 (en) * 1999-04-09 2016-06-16 Zoetis Services Llc Anti-bacterial vaccine compositions
AU2013201267B2 (en) * 1999-04-09 2016-03-17 Zoetis Services Llc Anti-bacterial vaccine compositions
US6790950B2 (en) 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
JP4892134B2 (ja) * 1999-04-09 2012-03-07 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌ワクチン組成物
GB9910812D0 (en) 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
PT1350796E (pt) * 2002-04-05 2009-01-23 Merial Sas Bactérias gram-negativas atenuadas
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
CN101496899B (zh) * 2004-08-20 2011-08-24 简茂盛 猪进行性萎缩性鼻炎的预防、治疗与检测
BRPI0519381A2 (pt) * 2004-12-22 2009-01-20 Intervet Int Bv bactÉria atenuada viva de pasteurella multocida, vacina atenuada viva para a proteÇço de animais ou humanos contra infecÇço por pasteurella multocida ou seu efeitos patogÊnicos, uso de uma bactÉria atenuada viva, mÉtodo para a preparaÇço de uma vacina, e, teste diagnàstico para a detecÇço de dna ou rna associado com pasteurella multocida
WO2008118902A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855408A (en) * 1973-07-16 1974-12-17 Univ Minnesota Poultry vaccine
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US4337314A (en) * 1979-05-23 1982-06-29 Research Corporation Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
US4293545A (en) * 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
ES2059503T5 (es) * 1987-03-24 2000-01-16 Btg International Limited Comp Procedimiento para preparar una vacuna contra pasteurella.
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine
US4999191A (en) * 1988-05-05 1991-03-12 University Of Georgia Research Foundation, Inc. Pasteurella multocida vaccine

Also Published As

Publication number Publication date
CA2148829A1 (en) 1994-05-26
EP0668779A1 (de) 1995-08-30
EP0668779A4 (de) 1996-08-21
WO1994011024A1 (en) 1994-05-26
JPH08503136A (ja) 1996-04-09

Similar Documents

Publication Publication Date Title
AU3693493A (en) Pyloroplasty/pylorectomy shield
AU3299995A (en) Protective feedthrough
AU3137295A (en) Glass compositions
AU2914392A (en) Cannula sealing mechanism
AU7812391A (en) Glass composition
AU4481193A (en) Glare elimination device
AU5794094A (en) Tricritical point composition
AU7138394A (en) N,n-diacylpiperazines
AU7134391A (en) Glass composition
AU5591694A (en) Composition protective against (p. multocida) pasteurellosis infection
AU6835990A (en) Instrumentation clamp
AU7437094A (en) Disinfectant-detergent composition
AU2960892A (en) Immunogen composition
AU5696496A (en) Anti-foaming composition
AU5950694A (en) Anticaries compositions
AU6106394A (en) An evacuation system
AU5773994A (en) Cable-making compositions
AU8079591A (en) Bisheterocyclic compound
AU7919494A (en) Duct protection
AU5049296A (en) Novel epicholesterol dehydrogenase
AU672124B2 (en) Composition
AU7686394A (en) Rectally-administered, epileptic-seizure-inhibiting composition
AU3384793A (en) 2-acetyl-3-keto-4,5-dihydrothiphene compounds
AU7468094A (en) Tnfalpha-secretion inhibitor containing syringin or its aglycone
AU7645594A (en) Protective faceshield